CLINICAL_TRIALS
trial_result
· 2012-05-03
Clinical Trial Update: Pemetrexed Plus Gemcitabine in Renal Cell Cancer [Phase 2]
Summary
Phase 2 trial evaluating pemetrexed plus gemcitabine in renal cell carcinoma was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Renal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2012-05-03